EURO-PERISCOPE
The European Platform for Research Outcomes after PerIoperative Interventions in Surgery for Cancer Research Group (Euro-Periscope): The Onco-Anaesthesiology Research Group (RG)
Chair: Daniela Ionescu (Iuliu Hatieganu University of Medicine and Pharmacy, Cluj, Romania).
Vice-Chair: Oscar Cambronero Diaz (Hospital Universitari i Politècnic la Fe, Valencia, Spain).
Honorary Chair: Donal Buggy (Dublin, Ireland)
Background
This network emerged from EU-COST Action 15204 (2016-2021) with the same name, EURO-PERISCOPE. This was an EU-funded network of doctors, mainly, but not exclusively, anaesthesiologists and also surgeons, nurses and scientists, actively engaged in perioperative care of the cancer patient. It was Chaired and instigated by Donal Buggy (Mater University Hospital, Dublin, Ireland). It focused on the research question: ‘Can anaesthetic, analgesic or perioperative interventions during tumour resection surgery influence risk of recurrence?” This collaborative network involved >120 participants in 22 European and near neighbour nations. The activities of the EU COST Action were halted in the final year of its term due to the Coronavirus pandemic. ESAIC Euro-Periscope RG will take over where the EU network ended, at least for the anaesthesiologists and affiliated scientists. At present, ESA-IC endorsed European Platform for Research Outcomes after Perioperative Interventions for Surgery for Cancer (Euro-Periscope) as a Research Group (RG) at the start of 2020.
ESA-IC Euro-Periscope Research Group’s vision and objectives
Vision
Onco-Anaesthesia Research Group vision is to promote international interdisciplinary scientific cooperation and research on the influence of perioperative period and anaesthetic interventions on the short and long term outcome of cancer patients undergoing surgery. Guidelines and evidence-based clinical practice recommendation will be formulated based on the results of scientific research.
Objectives
- To advocate for perioperative care of cancer patients, because complex cancer surgery for increasingly frail patients requires increasingly specialised care, meriting specific fellowship training and status as a recognised sub-specialty within anaesthesiology
- To promote research and quality improvement initiatives in perioperative management of cancer patients, focused not only on improving long term oncologic outcomes, but also on short term outcomes (e.g. QoR-15, Days at Home at 30 days, reduced 30-day complications, RIOT) that may also enhance longer term overall outcomes;
- To promote networking in research in anaesthesia and cancer between anaesthesiologists and other researchers/professionals in this field (surgeons, oncologists) from different countries from EU and around the world. Geographical diversity and gender equity as well as stimulating young researcher to join us are values of our group.
Members
Onco-Anaesthesia Research Group team includes 30 members (9 women and 21 men) from 16 countries, most countries in EU and USA (Belgium; Croatia; Denmark; France; Germany; Holland; Ireland; Italy; Romania; Serbia; Spain; Sweden; Switzerland; Turkey; UK).
Most of members are anaesthesiologists; there is 1 member surgeon.
Group members publish 25-30 articles annually on group topic- anaesthesia and cancer.
ESAIC current project
ENCORE. A prospective observational study sponsored by ESAIC.
Aiming for 10,000 Stage I-III colorectal cancer patients undergoing surgery of curative intent.
Primary objectives
1. To observe the effect of anaesthetic technique on:
2. Short term: time to start of adjuvant chemotherapy in patients planned for RIOT
3. Long term: Time to recurrence (TTR) at 2 years (± 1 month)
Secondary Objectives
1. 30-day postoperative morbidity
2. Length of hospital stay and Days at home at 30 days (DAH-30)
3. Adverse events related to oncological treatment (chemotherapy, radiotherapy)
4. 1-year mortality
Other current research projects
Cancer and Anaesthesia study (CAN) NCT01975064. 2024-2027 (Prof Mats Enlund)
2023-2025: Dutch Cancer Foundation KWF (#2022-3 DEV / 14719). Hollmann MW, Strien W, Steegers M, van Zuylen L, Kemper M. The SPACE PAIN Trial. Assessing the effect of Psilocybine on Chemotherapy-induced neuropathic pain
Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain (KALPAS) (ClinicalTrials.gov ID NCT05037123) (Prof Joshua Mincer)
Book editing project: group project
“Boosting the immune system of surgical cancer patients: a guide for onco-anesthesiology management” (Springer). Deadline: August 31, 2025 !